ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
-1.23%
S&P ASX All Technology
2,968.80
-1.53%
Brent Oil
85.035
-1.00%
US Dollar vs AUD
1.54206
-0.14%
Bitcoin
57,804.37
-4.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sophia Genetics SA (SOPH)

  7. Sophia Genetics SA (SOPH) News

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SOPH
DateTimeSourceHeadlineSymbolCompany
30/04/202421:05GlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
24/04/202400:29GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024NASDAQ:SOPHSophia Genetics SA
23/04/202419:05PR Newswire (US)SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaNASDAQ:SOPHSophia Genetics SA
17/04/202420:05PR Newswire (US)SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)NASDAQ:SOPHSophia Genetics SA
04/04/202416:00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
04/04/202416:00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
03/04/202401:00PR Newswire (US)Laboratorio Barnafi-Krause is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
21/03/202401:00PR Newswire (US)SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in CanadaNASDAQ:SOPHSophia Genetics SA
15/03/202421:00PR Newswire (US)SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear CollaborationNASDAQ:SOPHSophia Genetics SA
08/03/202404:07GlobeNewswire Inc.SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
05/03/202423:02Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SOPHSophia Genetics SA
05/03/202423:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
05/03/202422:45GlobeNewswire Inc.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:SOPHSophia Genetics SA
23/02/202400:45GlobeNewswire Inc.SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:SOPHSophia Genetics SA
21/02/202402:46GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024NASDAQ:SOPHSophia Genetics SA
07/02/202423:31PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
07/02/202422:51PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
26/01/202402:50PR Newswire (US)SOPHiA GENETICS Supports Genetic Testing in BrazilNASDAQ:SOPHSophia Genetics SA
19/01/202407:00PR Newswire (US)SOPHiA GENETICS Enhances RareCyte Precision Biology Services PortfolioNASDAQ:SOPHSophia Genetics SA
15/01/202415:00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
15/01/202415:00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
11/01/202409:15PR Newswire (US)SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
11/01/202408:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
09/01/202401:08PR Newswire (US)Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsNASDAQ:SOPHSophia Genetics SA
21/12/202323:00PR Newswire (US)Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid DisordersNASDAQ:SOPHSophia Genetics SA
15/12/202304:43GlobeNewswire Inc.SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
08/12/202301:01PR Newswire (US)SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy OfferingsNASDAQ:SOPHSophia Genetics SA
30/11/202323:01PR Newswire (US)SOPHiA GENETICS Announces Expansion of Work with CHU de NîmesNASDAQ:SOPHSophia Genetics SA
28/11/202323:00PR Newswire (US)SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di TorinoNASDAQ:SOPHSophia Genetics SA
17/11/202323:45PR Newswire (US)The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICSNASDAQ:SOPHSophia Genetics SA
 Showing the most relevant articles for your search:NASDAQ:SOPH

Your Recent History

COIN
ETHUSD
Ethereum
ASX
NAB
National Australia Bank
NYSE
DIS
Walt Disney
ASX
ORG
Origin Energy
NYSE
MCD
McDonalds
ASX
WPL
Woodside Petroleum
ASX
XAO
Australian SE All Ordina...
ASX
XTO
S&P ASX 100
ASX
BHP
BHP
NYSE
KO
Coca Cola
ASX
XMM
S&P ASX 300 Metals and M...
PM
XAUUSD
Gold vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved